AuB

About:

AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.

Website: https://aub.co.jp

Twitter/X: AuBinc_official

Top Investors: Mitsubishi UFJ Capital, Shizuoka Capital, Taiho Pharmaceutical Co, Fundinno, Taisho Pharmaceutical Holdings

Description:

AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.

Total Funding Amount:

634M JPY

Headquarters Location:

Ginza, Tokyo, Japan

Founded Date:

2015-01-01

Contact Email:

mail(AT)aub.co.jp

Founders:

Keita Suzuki

Number of Employees:

11-50

Last Funding Date:

2024-05-31

IPO Status:

Private

Industries: